Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Levakov, Sergey A
NCT06284265: Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis	Recruiting	3	632	RoW	Raphamin, MMH-407, Placebo	Materia Medica Holding	Cystitis Chronic, Cystitis Bacterial, Recurrence of Chronic Bacterial Cystitis	12/26	12/26
TUC3PII-01, NCT05138562 / 2020-000090-25: _TU2670 Phase IIa Clinical Study	Completed	2	86	Europe, RoW	Placebo Comparator: Placebo, Active Comparator: TU2670 320mg, Active Comparator: TU2670 240mg, Active Comparator: TU2670 120mg	TiumBio Co., Ltd., TiumBio Co. Ltd.	Endometriosis	01/24	08/24